Search
Close this search box.
Search
Subscriber Log In

Business Development & Licensing

Commercial Insight that Drives Successful Business Development & Licensing

Empower your success with strategic support. 

Success in the complex world of drug development and commercialisation requires careful consideration, strategic partnerships, and expert insights. At Evaluate, we underpin your success through customised strategic support so you can achieve your business development and licensing goals. 

Talk to us about your business development and licensing needs








Identify and Strategise Potential Partnerships

We go beyond asset assessment. We identify potential partnerships using an established and systematic approach to compare candidates based on commercial, clinical, and scientific criteria such as market novelty, potential revenue, competitive intensity, and partner suitability. 

Conduct Thorough Due Diligence and Valuation Analysis

We design our services to equip you with the necessary tools to conduct assessments of the positioning and revenue potential of assets or target assets. Make informed decisions on addressable patient populations, commercial potential scenarios, key variables, understand KOL and stakeholder opinions with our detailed analysis. We conduct thorough due diligence and raise awareness of the risks associated with potential transactions weighed against the potential return on investment.

Enhance Negotiation Strategies

We help navigate the partnership deal landscape identifying and emerging trends in external innovation, such as key players, indications, MOAs, or technologies. Access our deal data and insights to benchmark relevant deals, empowering you to strengthen your position during partnering negotiations.

Support Throughout the Transaction Process

We design our services to equip you with the necessary tools to conduct assessments of the positioning and revenue potential of assets or target assets. Make informed decisions on addressable patient populations, commercial potential scenarios, key variables, understand KOL and stakeholder opinions with our detailed analysis. We conduct thorough due diligence and raise awareness of the risks associated with potential transactions weighed against the potential return on investment.

How Our Solutions Support Business Development & Licensing

Evaluate Pharma

View current and forecasted financials, value R&D, and assess the worth of both marketed assets and pipelines by leveraging the unique connections between consensus forecasts and pipelines.

Evaluate Omnium

Uncover unique and highly accurate insights into assets and commercial opportunities by analyzing risk and return correlations. This valuable information helps in screening assets and making informed decisions.

Evaluate Epi

Accurately determine the commercial opportunities and the worth of potential assets through thorough scanning and assessment. This allows for the creation of a refined asset list and estimation of patient populations.

BioSciDB

Analyse the dealmaking landscape in detail. View key deal provisions, find deal comparables, and explore best practices in contract drafting and alliance negotiation.

Explore Another Use Case

Related Resources

Understand the context. Data-driven news and analysis for the pharma, biotech and medtech sectors.